| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb4507b39f5e0b8e92472aa0803efe05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62a022b438611a1149c2fef2b5b5c232 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| filingDate |
2003-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfc1bded4b82ac27fd4341309bfcd4d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaaafb142a207118f5606a01aa2b980f |
| publicationDate |
2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-537662-A |
| titleOfInvention |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| abstract |
Disclosed is a compound of formula I or a pharmaceutically acceptable salt thereof. Compounds of the type disclosed are useful in the treatment of flaviviridae infections, in particular hepatitis C. Also disclosed are combination therapies comprising said compound. |
| priorityDate |
2002-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |